| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Medicine II,*University of Luebeck, Luebeck; and the Department of Medicine III,University of Heidelberg, Heidelberg, Germany
Calcification of necrotic tissue is frequently observed in chronic inflammation and atherosclerosis. A similar response of myocardium to injury, referred to as dystrophic cardiac calcinosis (DCC), occurs in certain inbred strains of mice. We now examined a putative inhibitor of calcification, osteopontin, in DCC after transdiaphragmal myocardial freeze-thaw injury. Strong osteopontin expression was found co-localizing with calcification in DCC-susceptible strain C3H/HeNCrlBr, which exhibited low osteopontin plasma concentrations otherwise. Osteopontin mRNA induction was 20-fold higher than in resistant strain C57BL/6NCrlBr, which exhibited fibrous lesions without calcification and little osteopontin expression. Sequence analysis identified several polymorphisms in calcium-binding and phosphorylation sites in osteopontin cDNA. Their potential relevance for DCC was tested in congenic mice, which shared the osteopontin locus with C57BL/6NCrlBr, but retained a chromosomal segment from C3H/HeNCrlBr on proximal chromosome 7. These mice exhibited strong osteopontin expression and DCC comparable to C3H/HeNCrlBr suggesting that a trans-activator of osteopontin transcription residing on chromosome 7 and not the osteopontin gene on chromosome 5 was responsible for the genetic differences in osteopontin expression. A known osteopontin activator encoded by a gene on chromosome 7 is the transforming growth factor-ß1, which was more induced (3.5x) in C3H/HeNCrlBr than in C57BL/6NCrlBr mice.
This article has been cited by other articles:
 |
|
 |
|
  Z. Aherrahrou, L. C. Doehring, E.-M. Ehlers, H. Liptau, R. Depping, P. Linsel-Nitschke, P. M. Kaczmarek, J. Erdmann, and H. Schunkert An Alternative Splice Variant in Abcc6, the Gene Causing Dystrophic Calcification, Leads to Protein Deficiency in C3H/He Mice J. Biol. Chem., March 21, 2008; 283(12): 7608 - 7615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hendig, M. Arndt, C. Szliska, K. Kleesiek, and C. Gotting SPP1 Promoter Polymorphisms: Identification of the First Modifier Gene for Pseudoxanthoma Elasticum Clin. Chem., May 1, 2007; 53(5): 829 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Meng, I. Vera, N. Che, X. Wang, S. S. Wang, L. Ingram-Drake, E. E. Schadt, T. A. Drake, and A. J. Lusis Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics PNAS, March 13, 2007; 104(11): 4530 - 4535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Aherrahrou, L. C. Doehring, P. M. Kaczmarek, H. Liptau, E.-M. Ehlers, A. Pomarino, S. Wrobel, A. Gotz, B. Mayer, J. Erdmann, et al. Ultrafine mapping of Dyscalc1 to an 80-kb chromosomal segment on chromosome 7 in mice susceptible for dystrophic calcification Physiol Genomics, January 17, 2007; 28(2): 203 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Korff, F. Schoensiegel, N. Riechert, D. Weichenhan, H. A. Katus, and B. T. Ivandic Fine mapping of Dyscalc1, the major genetic determinant of dystrophic cardiac calcification in mice. Physiol Genomics, May 16, 2006; 25(3): 387 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hamerman Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies QJM, July 1, 2005; 98(7): 467 - 484. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
